p.95 抽出テキスト

文献

1. 日本医学会.医療における遺伝学的検査・診断に関するガイドライン.2011 年2 月(2022 年3 月改定).日本医学会.https://jams. med.or.jp/guideline/genetics-diagnosis_2022.pdf 2. 文部科学省,厚生労働省,経済産業省.人を対象とする生命科学・医学系研究に関する倫理指針.https://www.meti.go.jp/press/2022/ 03/20230327002/20230327002-1.pdf 3. 日本医学会,日本医師会.「遺伝情報・ゲノム情報による不当な差別や社会的不利益の防止」についての共同声明.https://www. med.or.jp/dl-med/teireikaiken/p20220406.pdf 4. 日本小児遺伝学会,日本先天異常学会,日本人類遺伝学会.診療において実施するマイクロアレイ染色体検査ガイダンス.https:// plaza.umin.ac.jp/p-genet/downloads/ 20200330_microarray_ guidance.pdf 5. 日本医療研究開発機構.未診断疾患イニシアチブ(IRUD). https://www.amed.go.jp/program/IRUD/ 6. 厚生労働科学研究費倫理的法的社会的課題研究事業. 国民が安心してゲノム医療を受けるための社会実現に向けた倫理社会的課題抽出と社会環境整備.令和2 年度総括研究報告書.https://mhlwgrants.niph.go.jp/system/files/report_pdf/ 2 0 2 0 0 4 0 0 1 Asokatsu_0.pdf 7. 厚生労働省.医療 ・介護関係事業者における個人情報の適切な取扱いのためのガイダンス.https://www.mhlw.go.jp/ content/001120905.pdf 8. 厚生労働省.診療情報の提供等に関する指針(平成15 年9 月12日 医政発第 0912001 号). 9. Miller DT, Lee K, Abul-Husn NS, et al. ACMG Secondary Findings Working Group. ACMG SF v 3 . 2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2023; 25: 100866. PMID: 37347242 10. Landstrom AP, Kim JJ, Gelb BD, et al. American Heart Association Council on Genomic and Precision Medicine; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Lifestyle and Cardiometabolic Health. Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association. Circ Genom Precis Med 2021; 14: e 000086. PMID: 34412507 11. Semsarian C, Gray B, Haugaa KH, et al. Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases: JACC Focus Seminar 3/ 4. J Am Coll Cardiol 2022; 80: 1268-1283. PMID: 36075839 12. 全国遺伝子医療部門連絡会議.http://www.idenshiiryoubumon. org/ 13. 難病情報センター.https://www.nanbyou.or.jp/ 14. 日本人類遺伝学会.DTC 遺伝学的検査に関する見解.https://jshg. jp/about/notice-reference/view-on-dtcgenetic-testing/ 15. Vorstman JA, Jalali GR, Rappaport EF, et al. MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat 2006; 27: 814-821. PMID: 16791841 16. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20: 207- 211. PMID: 9771718 17. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-764. PMID: 20466091 18. MacDonald JR, Ziman R, Yuen RK, et al. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 2014; 42: D 986-D 992. PMID: 24174537 19. Firth HV, Richards SM, Bevan AP, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 2009; 84: 524-533. PMID: 19344873 20. 日本小児内分泌学会 遺伝子診断委員会.保険収載されたマイクロアレイ染色体検査(CGH 法)の実際と注意点.http://jspe.umin. jp/medical/files/news_220315.pdf 21. Nurk S, Koren S, Rhie A, et al. The complete sequence of a human

genome. Science. 2022 Apr; 376( 6588): 44- 53. doi: 10. 1126/ science.abj6987. PMID: 35357919. 22 日本先天代謝異常学会.新生児マススクリーニング対象疾患等診

療ガイドライン.https://jsimd.net/pdf/newborn-mass-screening-disease-practice-guideline2019.pdf 23. 日本先天代謝異常学会.検査精密検査施設一覧:ライソゾーム病. http://jsimd.net/iof/iof_01.html 24. 国立成育医療研究センター.高度先進検査室.https://www.ncchd. go.jp/hospital/about/section/clinical/senshin.html 25. 厚生労働省.医療機関、衛生検査所等における検体検査に関する疑義解釈資料(Q&A).https://www.mhlw.go.jp/ content/10800000/000911184.pdf 26. College of American Pathologists. https://www.cap.org/ 27. 日本適合性認定協会.https://www.jab.or.jp/ 28. かずさDNA 研究所.かずさ遺伝子検査室.http://www.kazusa. or.jp/genetest/ 29. Takeda R, Yamaguchi T, Hayashi S, et al. Clinical and molecular features of patients with COL1-related disorders: Implications for the wider spectrum and the risk of vascular complications. Am J Med Genet A 2022; 188: 2560-2575. PMID: 35822426 30. Yamaguchi T, Hayashi S, Hayashi D, et al. Comprehensive genetic screening for vascular Ehlers-Danlos syndrome through an amplification-based next-generation sequencing system. Am J Med Genet A 2023; 191: 37-51. PMID: 36189931 30a.Yamaguchi T, Yamada K, Nagai S, et al. Clinical and molecular delineation of classical-like Ehlers-Danlos syndrome through a comprehensive next- generation sequencing-based screening system.Front Genet 2023; 14: 1234804, doi: 10. 3389/fgene. 2023.PMID: 37712068 31. IGV desktop application. Integrative Genomics Viewer (IGV). https://igv.org/doc/desktop/ 32. ClinGen. Gene-Disease Validity. https://search.clinicalgenome. org/kb/gene-validity 33. Thaxton C, Good ME, DiStefano MT, et al. ClinGen Gene Curation Working Group. Utilizing ClinGen gene-disease validity and dosage sensitivity curations to inform variant classification. Hum Mutat 2022; 43: 1031-1040. PMID: 34694049 34. gnomAD. https://gnomad.broadinstitute.org/ 35. jMorp. https://jmorp.megabank.tohoku.ac.jp/ 36. National Library of Medicine. ClinVar. https://www.ncbi.nlm.nih. gov/clinvar/ 36a. Global Variome shared LOVD. https://databases.lovd.nl/shared/ genes 37. MGeND: Medical Genomics Japan Variant Database. https:// mgend.ncgm.go.jp 38. Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424. PMID: 25741868 39. ClinGen. Sequence Variant Interpretation. https://clinicalgenome. org/working-groups/sequence-variant-interpretation/ 40. ClinGen. About ClinGen Expert Panels. https://www.clinicalgenome.org/affiliation/ 41. Fujiki R, Ikeda M, Yoshida A, et al. Assessing the Accuracy of Variant Detection in Cost-Effective Gene Panel Testing by Next-Generation Sequencing. J Mol Diagn 2018; 20: 572- 582. PMID: 29953964 42. Sequence Variant Nomenclature. https://varnomen.hgvs.org/ 43. Ison HE, Ware SM, Schwantes-An TH, et al. The impact of cardiovascular genetic counseling on patient empowerment. J Genet Couns 2019; 28: 570-577. PMID: 30680842 44. Cirino AL, Harris SL, Murad AM, et al. The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy A systematic review and meta-analysis. J Genet Couns 2022; 31: 1290-1305. PMID: 35799446 45. National Society of Genetic Counselors’ Definition Task Force. Resta R, Biesecker BB, Bennett RL, et al. A new definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force report. J Genet Couns 2006; 15: 77-83. PMID: 16761103 46. 臨床遺伝専門医制度委員会.20221201 臨床遺伝専門医行動目標. https://www.jbmg.jp/wp-content/uploads/2023/10/mokuhyo.pdf 47. 臨床遺伝専門医制度委員会.https://jbmg.jp/ 48. 認定遺伝カウンセラー制度委員会.認定遺伝カウンセラー到達目

標(20220423).https://plaza.umin.ac.jp/~GC/